Thursday, July 9, 2026

pharma · HER2-positive · CARM

Carisma Therapeutics

Carisma Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Philadelphia, USA HQ
2016 Founded
15 Employees
Public company Type
CARM · NYSE Ticker
Company details
Status
Public
HQ
Philadelphia, USA
Founded
2016
Employees
15
Programs
2
Drugs
1
Patents
2
Intelligence · Drug Pipeline

Carisma Therapeutics pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Carisma Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. Development asset linked to Carisma Therapeutics in public FDA and regional records.